Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.901
+0.001 (0.02%)
Nov 21, 2024, 1:22 PM EST - Market open
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VNDA stock have an average target of 15.5, with a low estimate of 13 and a high estimate of 18. The average target predicts an increase of 216.27% from the current stock price of 4.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VNDA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +267.29% | Oct 31, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +165.26% | Aug 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +124.45% | Jul 11, 2024 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +144.86% | Feb 25, 2022 |
Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +185.67% | Jan 14, 2021 |
Financial Forecast
Revenue This Year
202.53M
from 192.64M
Increased by 5.13%
Revenue Next Year
288.90M
from 202.53M
Increased by 42.65%
EPS This Year
-0.36
from 0.04
EPS Next Year
0.19
from -0.36
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 215.4M | 391.4M | 535.2M |
Avg | 202.5M | 288.9M | 336.3M |
Low | 188.1M | 225.4M | 194.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 11.8% | 93.2% | 85.3% |
Avg | 5.1% | 42.6% | 16.4% |
Low | -2.4% | 11.3% | -32.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.22 | 1.38 | 2.12 |
Avg | -0.36 | 0.19 | 1.03 |
Low | -0.47 | -0.47 | - |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 1,034.2% |
Avg | - | - | 450.9% |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.